共 50 条
- [24] Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (03): : 215 - 217
- [25] Cytomegalovirus and Epstein–Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation Annals of Hematology, 2011, 90 : 113 - 114
- [29] Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2009, 2 : 11 - 15